Victory Financial Group »

Halozyme Therapeutics shares owned by Victory Financial Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Victory Financial Group from 13F filings

Historical chart of Victory Financial Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Victory Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Victory Financial Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $823k 11k 78.27

More positions owned by Victory Financial Group

Ishares Tr Rus Tp200 Gr Etf (IWY)
Schwab Strategic Tr Us Dividend Eq (SCHD)
Ishares Tr MRGSTR MD CP GRW (IMCG)
Select Sector Spdr Tr St Str Techn Etf (XLK)
Fidelity Covington Trust High Divid Etf (FDVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Msci Intl Vlu Ft (IVLU)
Ishares Tr Core S&p Scp Etf (IJR)
NVIDIA Corporation (NVDA)
Pimco Etf Tr Multisector Bd (PYLD)
Spdr Series Trust St Str Sp600grwo (SLYG)
Bondbloxx Etf Trust Bloomberg One Yr (XONE)
Apple (AAPL)
Vanguard Index Fds Sm Cp Val Etf (VBR)
Spdr Index Shs Fds St Port Mark Etf (SPEM)

View all positions for Victory Financial Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Capital Management
Vanguard Portfolio Management
State Street Corporation
Invesco
Robeco Investment Management
Bank of America Corporation
Morgan Stanley
Geode Capital Management
William Blair Investment Management
Snyder Capital Management
Dimensional Fund Advisors
D. E. Shaw & Co
Thomas Stevens, CFA"
Royal London Asset Management

View all funds holding Halozyme Therapeutics